How Is Mitochondrial Health Measured? The Biomarkers Researchers Use
Key takeaways
- There is no single "mitochondria score." Researchers combine functional tests, tissue biopsies, imaging, and blood biomarkers to build a picture of how well your cells make energy.
- In HUMAN urolithin A trials, the most-used readouts were plasma acylcarnitines, peak VO2, muscle strength and fatigue resistance, and mitochondrial gene expression from muscle biopsies.
- Plasma acylcarnitines are a window on fatty-acid oxidation; a drop is generally read as more efficient mitochondrial fuel use.
- The mitochondrial-to-nuclear DNA ratio and oxidative-phosphorylation enzyme levels estimate how many functional mitochondria a tissue carries.
- Most lab measures require a clinic or a research setting; at home, trackable proxies like VO2 estimates, walking endurance, and recovery are the practical stand-ins.
"How healthy are my mitochondria?" sounds like it should have a one-number answer, the way a blood-pressure cuff gives you 120/80. It doesn't. Mitochondria are tiny, they behave differently in different tissues, and the thing that matters most — how efficiently they turn fuel and oxygen into usable energy — can't be read directly from a drop of blood. So scientists triangulate. They stack together functional performance tests, tissue samples, imaging, and circulating biomarkers, and they look for changes across several of them at once.
This matters for anyone following the research on mitochondrial support, including standardized Urolithin A, because every credible claim rests on one of these measurement tools. Knowing what the tools actually capture — and what they can't — is the difference between reading a study and being sold a story.
Why is mitochondrial health so hard to measure directly?
A mitochondrion's core job is oxidative phosphorylation: shuttling electrons down a membrane-bound chain to generate ATP, your cells' energy currency. Measuring that process in a living person, non-invasively, is genuinely difficult. The gold-standard laboratory method — high-resolution respirometry on freshly isolated mitochondria — requires a tissue biopsy and specialized equipment, so it's confined to research settings.
On top of that, mitochondrial quality is not the same as mitochondrial quantity. You can have many mitochondria that work poorly, or fewer that work well. Healthy tissue constantly builds new mitochondria (biogenesis) and clears damaged ones (a recycling process called mitophagy). A good measurement strategy tries to capture both halves of that balance, which is why researchers rarely rely on any single readout.
What biomarkers do researchers actually use?
Below is a plain-language map of the main tools, roughly from "most accessible" to "research-only," and what each one is really telling you.
| Measure | What it reflects | Where it's done |
|---|---|---|
| Peak VO2 (aerobic capacity) | Whole-body oxygen use; indirectly, muscle mitochondrial capacity | Clinic / lab (treadmill or bike test) |
| Muscle strength & fatigue resistance | Functional output of energy-producing muscle | Clinic or field test |
| Phosphocreatine (PCr) recovery via 31P-MRS | How fast muscle restores its energy buffer — a direct-ish functional read of mitochondria | Research MRI |
| Plasma acylcarnitines | Fatty-acid oxidation efficiency; a drop suggests cleaner fuel processing | Blood draw + metabolomics |
| mtDNA-to-nuclear DNA ratio | Approximate mitochondrial abundance in a tissue | Tissue biopsy |
| Oxidative-phosphorylation enzyme levels | Amount of working electron-transport machinery | Tissue biopsy |
| Gene-expression signatures (e.g., mitophagy genes) | Whether cellular quality-control programs are switched on | Tissue biopsy + sequencing |
Two features of this list are worth underlining. First, the most informative measures (biopsy and MRI) are the least practical for everyday use. Second, the blood markers — especially plasma acylcarnitines — are attractive precisely because a single draw can hint at how well fat is being fed into the mitochondrial furnace.
What did the urolithin A human trials actually measure?
Urolithin A is a useful case study because its clinical program leaned on this exact toolkit. In the first-in-human study (Andreux and colleagues, 2019, Nature Metabolism; HUMAN), four weeks of supplementation in older adults was associated with a decrease in several plasma acylcarnitines and with dose-dependent increases in the expression of mitochondrial and mitophagy-related genes in muscle tissue (Andreux et al., 2019).
A later randomized trial in middle-aged adults (Singh and colleagues, 2022, Cell Reports Medicine; HUMAN) layered on functional and tissue measures: it reported improvements in muscle strength and roughly a 10% change in peak VO2 versus placebo, a rise in the mitochondrial-to-nuclear DNA ratio, higher oxidative-phosphorylation enzyme levels, and an increase in Parkin activation (a mitophagy marker) in muscle biopsies (Singh et al., 2022). A separate randomized trial in adults aged 65–90 (Liu and colleagues, 2022, JAMA Network Open; HUMAN) used muscle fatigue resistance as a primary readout and reported about a 20% improvement at two months, alongside reductions in acylcarnitines and the inflammatory marker C-reactive protein (Liu et al., 2022).
The foundational mechanism — that urolithin A triggers mitophagy — was first established in worms and rodents (Ryu and colleagues, 2016, Nature Medicine; PRECLINICAL), using upregulation of mitophagy genes as the key marker (Ryu et al., 2016). It's a good reminder that gene-expression signatures carry different weight depending on whether they come from a model organism or a human biopsy.
A fair-minded reading keeps the caveats visible. Several of these measures are proxies, some trial endpoints did not reach statistical significance (for example, walking-distance changes in the older-adult study), and narrative reviews summarizing the data have been authored by parties connected to the compound's developer (Liang et al., 2024, review). None of that erases the findings; it just means the numbers should be read as a converging pattern rather than proof of any single benefit.
Can you measure your own mitochondrial health at home?
Not with laboratory precision — but the functional proxies researchers trust are things you can loosely track yourself. A wearable's VO2-max estimate, how far you can walk or run before fatigue sets in, how quickly your heart rate recovers after a hard effort, and your day-to-day stamina all move in the same direction as the underlying measures. They're noisy, but a sustained trend over months is more meaningful than any single reading.
If you're experimenting with mitochondrial support such as SOMA Urolithin A gummies, those same proxies are the sensible things to watch, over a realistic window of weeks to months rather than days.
What does this mean for choosing a supplement?
The practical lesson is to be skeptical of any product that claims to "measure" or instantly "boost" your mitochondria. The serious research uses a careful, multi-tool approach and still speaks in cautious, probabilistic language. When you evaluate a supplement, look for whether its claims trace back to these kinds of measures in actual trials — and whether the human evidence is distinguished from preclinical work (scoping review, 2023).
Frequently asked questions
Is there a single blood test for mitochondrial health?
No. There is no validated, single blood test that scores overall mitochondrial health. Clinicians investigating specific mitochondrial disorders use panels of tests, but for general "cellular energy" there is no one number — researchers combine several markers.
What are acylcarnitines and why do they matter?
Acylcarnitines are molecules that carry fatty acids into mitochondria to be burned for energy. Their pattern in blood reflects how efficiently that process runs. In several urolithin A trials, certain acylcarnitines decreased, which researchers interpreted as more efficient fuel handling.
Does a higher VO2 max mean healthier mitochondria?
Broadly, higher aerobic capacity is associated with greater muscle mitochondrial capacity, which is why VO2 peak is used as a functional proxy. It's influenced by many factors beyond mitochondria, so it's one signal among several, not a direct readout.
How long before supplement-related changes would show up on these measures?
The human trials ran from four weeks to four months. Functional and biomarker shifts, where observed, generally emerged over that kind of window — not within days. Any self-tracking should use a similar multi-week horizon.
Can lifestyle change these markers?
Yes. Endurance and resistance exercise are the best-established ways to improve many of these functional and tissue measures. Supplements such as standardized Urolithin A are studied as complements to, not replacements for, physical activity.
Support your cellular health, every day
SOMA delivers a high-potency 1,000 mg dose of Urolithin A in one simple daily gummy — no guesswork, no converter-status lottery.
Shop SOMA Urolithin A Gummies →These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.